SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-396095
Filing Date
2012-09-19
Accepted
2012-09-19 07:53:46
Documents
4
Period of Report
2012-09-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d413594d8k.htm 8-K 16754
2 PRESS RELEASE d413594dex991.htm EX-99.1 8076
3 GRAPHIC g413594001.jpg GRAPHIC 17120
4 GRAPHIC g413594002.jpg GRAPHIC 7861
  Complete submission text file 0001193125-12-396095.txt   60842
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 121098744
SIC: 2834 Pharmaceutical Preparations